On the whole, cross-reactions hitting adiponectin might lead to obesity, metabolic syndrome, diabetes, endothelial dysfunction, atherosclerosis, hypertension, and coronary artery disease [52]. This evidence concerns the gene ADIPOQ and metabolic syndrome.